QT
XLRN

Quantamental Technologies’s Acceleron Pharma XLRN Stock Holding History

Quantamental Technologies’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,695
Closed -$185K – 1550
2019
Q3 		$185K Buy
+4,695
New +$204K 0.06% 528

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Quantamental Technologies's XLRN Position: Q4 2019 in Review

Quantamental Technologies sold out of Acceleron Pharma (XLRN) in Q4 2019, closing a stake of 4,695 shares — an estimated $185K sold.

Quantamental Technologies first reported a position in XLRN in Q3 2019 and held it in 1 quarter. The position peaked at $185K in Q3 2019. 183 funds tracked by Wall St. Rank hold XLRN as of Q4 2019.

  • Quantamental Technologies reported no remaining Acceleron Pharma position as of Q4 2019 after selling out during the quarter.
  • Quantamental Technologies sold 4,695 Acceleron Pharma shares in Q4 2019, an estimated $185K.
  • Quantamental Technologies first reported a position in Acceleron Pharma in Q3 2019 and held it in 1 quarter.
  • Quantamental Technologies's Acceleron Pharma position peaked at $185K in Q3 2019.
  • 183 funds tracked by Wall St. Rank held Acceleron Pharma as of Q4 2019.

Based on Quantamental Technologies's 13F filing for Q4 2019, filed 14 Feb 2020.